Health Care
Business & Economics
New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs
It’s easy for politicians and consumers to rage about the high price of prescription drugs, but Wayne Winegarden, Pacific Research Institute’s senior fellow in business and economics, said those prices are not to blame for the high cost of healthcare in the United States. Recently, U.S. Bernie Sanders has been ...
Business & Economics
Pharmacy Benefit Managers Add Cost To Healthcare, Impose Consumer And Market Burdens, Study Says
Due to inefficiencies in the current regulatory framework, pharmacy benefit managers can add cost to the healthcare system and impose burdens on both consumers and market competition, according to a new study released by the Pacific Research Institute. PBMs — essentially middlemen who process prescription transactions, negotiate drug discounts and ...
Commentary
We Can’t Keep Accepting Failures And The VA
Rewarding failure appears to be something of a tradition at the Department of Veterans Affairs. A few weeks ago, President Trump kept up that tradition by signing the Veterans Choice Improvement Act, which extends the beleaguered Veterans Choice program. That initiative, originally due to expire in August, gives select veterans ...
Commentary
Time To Face Facts On Pre-Existing Conditions
Democrats have assailed the American Health Care Act, which narrowly passed the House by four votes on May 4, for supposedly ripping away Obamacare’s protections for people with pre-existing conditions. House Minority Leader Nancy Pelosi, D-Calif., called the bill’s approach to covering such conditions a “sad, deadly joke.” Rep. Frank ...
Commentary
The Trump Administration Is Making Life Harder For Obamacare’s Freeloaders
While Congressional Republicans continue to hash out their plan to repeal and replace Obamacare, the executive branch has already taken action to undo some of the law’s most destructive features. Last month, the Centers for Medicare & Medicaid Services (CMS) cut the enrollment period for 2018 Obamacare exchange plans from ...
Business & Economics
Empower Patients, Not ICER
An obscure institute that most people have never heard of threatens to impose unwarranted restrictions on medically-advised treatments for patients. The Institute for Clinical and Economic Review, or ICER as it is commonly known, assesses whether medicines are cost effective, based on ICER’s definition, of course. These assessments are intended ...
Commentary
On the Republican Alternatives to Obamacare
Or, to put it in other words: The federal government should give the American people the health-care dollars it currently gives to our employers. Republican leaders really muddy this issue. To wit: Karl Rove’s advice in yesterday’s Wall Street Journal. Read the entire post here .
Business & Economics
It’s Time To Switch Our Pharmacy Benefit Manager
Click here to read PRI’s new issue brief, The Economic Costs of Pharmacy Benefit Managers Express Scripts, the largest pharmacy benefit manager (PBM) in the nation, is discovering just how much customer service matters. It may also be discovering that suing your biggest customer in court is generally not considered ...
Health Care
New Brief Highlights The Economic Costs Of Pharmacy Benefit Managers
Exploring a tool that millions of Americans use every day when paying for prescription drugs, the Pacific Research Institute today released a new research brief exploring how Pharmacy Benefit Managers (PBMs) impact prescription drug costs, access, and patient care. “Pharmacy Benefit Managers impact more than 260 million Americans when they ...
Commentary
Sally Pipes Talks House AHCA Vote on Newsmax TV
PRI President and CEO Sally Pipes discuss the House vote to pass the American Health Care Act with Steve Malzberg on Newsmax TV.
New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs
It’s easy for politicians and consumers to rage about the high price of prescription drugs, but Wayne Winegarden, Pacific Research Institute’s senior fellow in business and economics, said those prices are not to blame for the high cost of healthcare in the United States. Recently, U.S. Bernie Sanders has been ...
Pharmacy Benefit Managers Add Cost To Healthcare, Impose Consumer And Market Burdens, Study Says
Due to inefficiencies in the current regulatory framework, pharmacy benefit managers can add cost to the healthcare system and impose burdens on both consumers and market competition, according to a new study released by the Pacific Research Institute. PBMs — essentially middlemen who process prescription transactions, negotiate drug discounts and ...
We Can’t Keep Accepting Failures And The VA
Rewarding failure appears to be something of a tradition at the Department of Veterans Affairs. A few weeks ago, President Trump kept up that tradition by signing the Veterans Choice Improvement Act, which extends the beleaguered Veterans Choice program. That initiative, originally due to expire in August, gives select veterans ...
Time To Face Facts On Pre-Existing Conditions
Democrats have assailed the American Health Care Act, which narrowly passed the House by four votes on May 4, for supposedly ripping away Obamacare’s protections for people with pre-existing conditions. House Minority Leader Nancy Pelosi, D-Calif., called the bill’s approach to covering such conditions a “sad, deadly joke.” Rep. Frank ...
The Trump Administration Is Making Life Harder For Obamacare’s Freeloaders
While Congressional Republicans continue to hash out their plan to repeal and replace Obamacare, the executive branch has already taken action to undo some of the law’s most destructive features. Last month, the Centers for Medicare & Medicaid Services (CMS) cut the enrollment period for 2018 Obamacare exchange plans from ...
Empower Patients, Not ICER
An obscure institute that most people have never heard of threatens to impose unwarranted restrictions on medically-advised treatments for patients. The Institute for Clinical and Economic Review, or ICER as it is commonly known, assesses whether medicines are cost effective, based on ICER’s definition, of course. These assessments are intended ...
On the Republican Alternatives to Obamacare
Or, to put it in other words: The federal government should give the American people the health-care dollars it currently gives to our employers. Republican leaders really muddy this issue. To wit: Karl Rove’s advice in yesterday’s Wall Street Journal. Read the entire post here .
It’s Time To Switch Our Pharmacy Benefit Manager
Click here to read PRI’s new issue brief, The Economic Costs of Pharmacy Benefit Managers Express Scripts, the largest pharmacy benefit manager (PBM) in the nation, is discovering just how much customer service matters. It may also be discovering that suing your biggest customer in court is generally not considered ...
New Brief Highlights The Economic Costs Of Pharmacy Benefit Managers
Exploring a tool that millions of Americans use every day when paying for prescription drugs, the Pacific Research Institute today released a new research brief exploring how Pharmacy Benefit Managers (PBMs) impact prescription drug costs, access, and patient care. “Pharmacy Benefit Managers impact more than 260 million Americans when they ...
Sally Pipes Talks House AHCA Vote on Newsmax TV
PRI President and CEO Sally Pipes discuss the House vote to pass the American Health Care Act with Steve Malzberg on Newsmax TV.
